GO:0048026

BP

positive regulation of mRNA splicing, via spliceosome

Any process that activates or increases the rate or extent of mRNA splicing via a spliceosomal mechanism.

RBMX, TRA2B, DAZAP1, PRPF19, THRAP3

GO:0048041

BP

focal adhesion assembly

The aggregation and bonding together of a set of components to form a focal adhesion, a complex of intracellular signaling and structural proteins that provides a structural link between the internal actin cytoskeleton and the ECM, and also function as a locus of signal transduction activity.

RHOD, ARHGAP6, BCL2, ACTN1, ITGA2, ACTN2, ARHGEF7, CTTN, PTPRK, TRIP6, AJUBA, DLC1, SORBS1, TAOK2

GO:0048048

BP

embryonic eye morphogenesis

The process occurring in the embryo by which the anatomical structures of the post-embryonic eye are generated and organized.

AXIN1, FBN1, FBN2, ALDH1A3, MFAP2, FOXL2, EFEMP1

GO:0048050

BP

post-embryonic eye morphogenesis

The process, occurring after embryonic development, by which the anatomical structures of the eye are generated and organized. The eye is the organ of sight.

FBN1, MFAP2, EFEMP1

GO:0048066

BP

developmental pigmentation

The developmental process that results in the deposition of coloring matter in an organism, tissue or cell.

BCL2L11, ZEB2, GNA11, PMEL, GNAQ, SLC45A2

GO:0048070

BP

regulation of developmental pigmentation

Any process that modulates the frequency, rate or extent of the developmental process that results in the deposition of coloring matter in an organism.

BCL2L11, KIT

GO:0048075

BP

positive regulation of eye pigmentation

Any process that activates or increases the frequency, rate or extent of establishment of a pattern of pigment in the eye of an organism.

HPS4

GO:0048087

BP

positive regulation of developmental pigmentation

Any process that increases the frequency, rate or extent of the developmental process that results in the deposition of coloring matter in an organism.

BAX

GO:0048096

BP

chromatin-mediated maintenance of transcription

Maintenance of transcription by remodelling of chromatin into an 'open configuration'. Once established, this regulation is mitotically stable and is maintained over many cell divisions. It is also heritable.

ARID1A, CHEK1, CTNNB1, ELOF1, ARID1B, SMARCD1, BAZ1B, KMT2B

GO:0048102

BP

autophagic cell death

A form of programmed cell death that is accompanied by the formation of autophagosomes. Autophagic cell death is characterized by lack of chromatin condensation and massive vacuolization of the cytoplasm, with little or no uptake by phagocytic cells.

LAMP1, CDKN1B, BNIP3, TP53INP1, SH3GLB1

GO:0048103

BP

somatic stem cell division

The self-renewing division of a somatic stem cell, a stem cell that can give rise to cell types of the body other than those of the germ-line.

FZD7, KIT, NOTCH1, ZFP36L2, TGFB2

GO:0048133

BP

male germ-line stem cell asymmetric division

The self-renewing division of a germline stem cell in the male gonad, to produce a daughter stem cell and a daughter germ cell, which will divide to form the male gametes.

ETV5, ZBTB16

GO:0048143

BP

astrocyte activation

A change in morphology and behavior of an astrocyte resulting from exposure to a cytokine, chemokine, cellular ligand, or soluble factor.

EGFR, MT1X

GO:0048144

BP

fibroblast proliferation

The multiplication or reproduction of fibroblast cells, resulting in the expansion of the fibroblast population.

AGT

GO:0048145

BP

regulation of fibroblast proliferation

Any process that modulates the frequency, rate or extent of multiplication or reproduction of fibroblast cells.

CREB1, CTNNB1

GO:0048146

BP

positive regulation of fibroblast proliferation

Any process that activates or increases the frequency, rate or extent of multiplication or reproduction of fibroblast cells.

EREG, NDUFS4, EGFR, AGT, MYC, PDGFB, TGFB1, FN1, ESR1, PDGFA, CD74, IGF1, JUN, S100A6, ANXA2, WNT2, PDGFRB, CDK4, MIF, CCNB1, FOSL2, PDGFRA, CCNA2, BTC, CDKN1A, WNT5A, PRKDC, CDK6, E2F1, GAS6, RNASEH2B, WAPL, CDC6, PDGFD, PDGFC, SPHK1, ZMIZ1

GO:0048147

BP

negative regulation of fibroblast proliferation

Any process that stops, prevents, or reduces the frequency, rate or extent of multiplication or reproduction of fibroblast cells.

NUPR1, MYC, FTH1, TP53, GSTP1, SKI, AGTR2, EMD, BAX, PMAIP1, MORC3, SFRP1, PAWR, DACH1

GO:0048148

BP

behavioral response to cocaine

Any process that results in a change in the behavior of an organism as a result of a cocaine stimulus.

DRD2, SNCA, ABAT, CDK5, SDK1, HOMER1

GO:0048149

BP

behavioral response to ethanol

Any process that results in a change in the behavior of an organism as a result of an ethanol stimulus.

DRD2, CHRNA7, USP46, EPS8, HDAC2

GO:0048160

BP

primary follicle stage

The stage in oogenesis when a single layer of cuboidal follicle cells surrounds the oocyte. The oocyte nucleus is large.

EREG

GO:0048167

BP

regulation of synaptic plasticity

A process that modulates synaptic plasticity, the ability of synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.

NCAM1, ITPKA, HRH1, PSEN1, CDK5, YWHAH, MEF2C, EIF4EBP2, NFATC4, CNTN4, CPEB3, FGF14, SYNGAP1, PLK2, LZTS1

GO:0048168

BP

regulation of neuronal synaptic plasticity

A process that modulates neuronal synaptic plasticity, the ability of neuronal synapses to change as circumstances require. They may alter function, such as increasing or decreasing their sensitivity, or they may increase or decrease in actual numbers.

APOE, S100B, EGR2, STAR, DBN1, NSMF, ARC

GO:0048169

BP

regulation of long-term neuronal synaptic plasticity

A process that modulates long-term neuronal synaptic plasticity, the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers.

AGT, KRAS, DRD2, SNCA, RAB11A, DLG4, SYNGAP1

GO:0048170

BP

positive regulation of long-term neuronal synaptic plasticity

A process that increases long-term neuronal synaptic plasticity, the ability of neuronal synapses to change long-term as circumstances require. Long-term neuronal synaptic plasticity generally involves increase or decrease in actual synapse numbers.

KIT, EPHB2

GO:0048172

BP

regulation of short-term neuronal synaptic plasticity

A process that modulates short-term neuronal synaptic plasticity, the ability of neuronal synapses to change in the short-term as circumstances require. Short-term neuronal synaptic plasticity generally involves increasing or decreasing synaptic sensitivity.

RAB3GAP1, SHISA6

GO:0048178

BP

negative regulation of hepatocyte growth factor biosynthetic process

Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of hepatocyte growth factor.

INHBB

GO:0048193

BP

Golgi vesicle transport

The directed movement of substances into, out of or within the Golgi apparatus, mediated by vesicles.

CYTH3, STX6, PRKD1

GO:0048194

BP

Golgi vesicle budding

The evagination of the Golgi membrane, resulting in formation of a vesicle.

PRKCI

GO:0048199

BP

vesicle targeting, to, from or within Golgi

The process in which vesicles are directed to specific destination membranes during transport to, from or within the Golgi apparatus; mediated by the addition of specific coat proteins, including COPI and COPII proteins and clathrin, to the membrane during vesicle formation.

TMED10

GO:0048203

BP

vesicle targeting, trans-Golgi to endosome

The process in which vesicles are directed to specific destination membranes during transport from the trans-Golgi to the endosome.

WIPI1

GO:0048205

BP

COPI coating of Golgi vesicle

The addition of COPI proteins and adaptor proteins to Golgi membranes during the formation of transport vesicles, forming a vesicle coat.

TMED10, TMED2, GBF1

GO:0048208

BP

COPII vesicle coating

The addition of COPII proteins and adaptor proteins to ER membranes during the formation of transport vesicles, forming a vesicle coat.

PPP6C, GOSR2, ANKRD28, SEC22B, TRAPPC6A, SEC24D, SEC31A, F8, SERPINA1, TGFA, TRAPPC2, F5, FOLR1, AREG, NSF, TRAPPC10, CSNK1D, TMED10, CTSC, SEC13, RAB1A, GOLGA2, CUL3, TMED2, SEC23A, KLHL12, TRAPPC5, MCFD2, TFG, SEC16B, RAB1B, CTSZ, PPP6R1, TRAPPC1, SAR1B

GO:0048211

BP

Golgi vesicle docking

The initial attachment of a Golgi transport vesicle membrane to a target membrane, mediated by proteins protruding from the membrane of the Golgi vesicle and the target membrane.

NSF

GO:0048227

BP

plasma membrane to endosome transport

Transport of a vesicle from the plasma membrane to the endosome.

RAB5C, RAB5B, RAB11A, COMMD1, USP6NL

GO:0048232

BP

male gamete generation

Generation of the male gamete; specialised haploid cells produced by meiosis and along with a female gamete takes part in sexual reproduction.

MCM8

GO:0048240

BP

sperm capacitation

A process required for sperm to reach fertilization competence. Sperm undergo an incompletely understood series of morphological and molecular maturational processes, termed capacitation, involving, among other processes, protein tyrosine phosphorylation and increased intracellular calcium.

DLD, CFTR, PRKACA

GO:0048241

BP

epinephrine transport

The directed movement of epinephrine into, out of or within a cell, or between cells, by means of some agent such as a transporter or pore.

SLC22A1

GO:0048243

BP

norepinephrine secretion

The regulated release of norepinephrine by a cell. Norepinephrine is a catecholamine and it acts as a hormone and as a neurotransmitter of most of the sympathetic nervous system.

NISCH

GO:0048245

BP

eosinophil chemotaxis

The movement of an eosinophil in response to an external stimulus.

CCL3, CCL5, SCG2, LGALS3, HRH1

GO:0048246

BP

macrophage chemotaxis

The movement of a macrophage in response to an external stimulus.

SAA1, CCL3, CCL2, CCL5, LGALS3, EDN2, NUP85, CKLF

GO:0048247

BP

lymphocyte chemotaxis

The directed movement of a lymphocyte in response to an external stimulus.

SAA1, CCL3, CCL4, CCL2, ADAM8, CCL20, CCL8, CKLF

GO:0048250

BP

mitochondrial iron ion transport

The directed movement of iron ions into, out of or within a mitochondrion.

SLC25A37

GO:0048251

BP

elastic fiber assembly

Assembly of the extracellular matrix fibers that enables the matrix to recoil after transient stretching.

TNXB, LOX, MYH11, THSD4

GO:0048255

BP

mRNA stabilization

Prevention of degradation of mRNA molecules. In the absence of compensating changes in other processes, the slowing of mRNA degradation can result in an overall increase in the population of active mRNA molecules.

MEIOC, SLC11A1, E2F1, CIRBP, HNRNPD, ELAVL1, PAIP1, NOCT, THRAP3

GO:0048260

BP

positive regulation of receptor-mediated endocytosis

Any process that activates or increases the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport.

HIP1, TF, VTN, SERPINE1, PPT1, B2M, HFE, LDLRAP1, APOA5, BICD1, RAB21

GO:0048261

BP

negative regulation of receptor-mediated endocytosis

Any process that stops, prevents, or reduces the frequency, rate or extent of receptor mediated endocytosis, the uptake of external materials by cells, utilizing receptors to ensure specificity of transport.

APOC1, APOC3, RAC1, PICALM, RABGEF1

GO:0048263

BP

determination of dorsal identity

Determination of the identity of part of an organism or organ where those parts are of the type that occur in the dorsal region. Identity is considered to be the aggregate of characteristics by which a structure is recognized.

GREM1, NBL1, GREM2

GO:0048265

BP

response to pain

Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a pain stimulus. Pain stimuli cause activation of nociceptors, peripheral receptors for pain, include receptors which are sensitive to painful mechanical stimuli, extreme heat or cold, and chemical stimuli.

COMT

GO:0048266

BP

behavioral response to pain

Any process that results in a change in the behavior of an organism as a result of a pain stimulus. Pain stimuli cause activation of nociceptors, peripheral receptors for pain, include receptors which are sensitive to painful mechanical stimuli, extreme heat or cold, and chemical stimuli.

THBS1, TSPO, THBS4, GIT2, SCN9A, TRPV1

GO:0048268

BP

clathrin coat assembly

The process that results in the assembly of clathrin triskelia into the ordered structure known as a clathrin cage.

HIP1, PIK3C2A, EPS15, NSG1, AP2S1, AP2B1, FCHO2, PICALM

GO:0048278

BP

vesicle docking

The initial attachment of a transport vesicle membrane to the target membrane, mediated by proteins protruding from the membrane of the vesicle and the target membrane. Docking requires only that the two membranes come close enough for these proteins to interact and adhere.

EXOC5, STX7, STX6, STX11, SYT1, STX2, CAV2, STX4, STX3, BVES, NDRG4, CEP83

GO:0048280

BP

vesicle fusion with Golgi apparatus

The joining of the lipid bilayer membrane around a vesicle to the lipid bilayer membrane around the Golgi.

GOSR2, SEC22B, VAMP7, SEC22A, VTI1B

GO:0048284

BP

organelle fusion

The creation of a single organelle from two or more organelles.

STX4

GO:0048286

BP

lung alveolus development

The process whose specific outcome is the progression of the alveolus over time, from its formation to the mature structure. The alveolus is a sac for holding air in the lungs; formed by the terminal dilation of air passageways.

FOXP2, TCF21, HS6ST1, ADA, PDGFA, BMP4, LIF, EDN2, FGFR2, IGFBP5, FLT4, BMPR2, PDPN, CIC, HOPX, RC3H2, SEPN1, ERRFI1, MAPK8IP3

GO:0048291

BP

isotype switching to IgG isotypes

The switching of activated B cells from IgM biosynthesis to biosynthesis of an IgG isotype, accomplished through a recombination process involving an intrachromosomal deletion between switch regions that reside 5' of the IgM and one of the IgG constant region gene segments in the immunoglobulin heavy chain locus.

HSPD1

GO:0048294

BP

negative regulation of isotype switching to IgE isotypes

Any process that stops, prevents, or reduces the frequency, rate or extent of isotype switching to IgE isotypes.

BCL6, NDFIP1, FOXP3

GO:0048295

BP

positive regulation of isotype switching to IgE isotypes

Any process that activates or increases the frequency, rate or extent of isotype switching to IgE isotypes.

CLCF1

GO:0048298

BP

positive regulation of isotype switching to IgA isotypes

Any process that activates or increases the frequency, rate or extent of isotype switching to IgA isotypes.

TNFSF13, WHSC1, TGFB1

GO:0048302

BP

regulation of isotype switching to IgG isotypes

Any process that modulates the frequency, rate or extent of isotype switching to IgG isotypes.

NDFIP1, FOXP3

GO:0048304

BP

positive regulation of isotype switching to IgG isotypes

Any process that activates or increases the frequency, rate or extent of isotype switching to IgG isotypes.

CD28

GO:0048305

BP

immunoglobulin secretion

The regulated release of immunoglobulins from a B cell or plasma cell, whose mechanism includes the use of alternate polyadenylylation signals to favor the biosynthesis of secreted forms of immunoglobulin over membrane-bound immunoglobulin.

TRAF3IP2, CD40LG, TNFSF13B

GO:0048311

BP

mitochondrion distribution

Any process that establishes the spatial arrangement of mitochondria between and within cells.

MEF2A, MTM1

GO:0048312

BP

intracellular distribution of mitochondria

Any process that establishes the spatial arrangement of mitochondria within the cell.

SYNJ2BP

GO:0048318

BP

axial mesoderm development

The process whose specific outcome is the progression of the axial mesoderm over time, from its formation to the mature structure. The axial mesoderm includes the prechordal mesoderm and the chordamesoderm. It gives rise to the prechordal plate and to the notochord.

RPL38

GO:0048320

BP

axial mesoderm formation

The process that gives rise to the axial mesoderm. This process pertains to the initial formation of the structure from unspecified parts.

AXIN1

GO:0048333

BP

mesodermal cell differentiation

The process in which a relatively unspecialized cell acquires the specialized features of a mesoderm cell.

KDM6A, ITGB3, ITGB1, INHBA, ITGB4, ITGA2, FGFR2, ITGA3, HMGA2

GO:0048339

BP

paraxial mesoderm development

The process whose specific outcome is the progression of the paraxial mesoderm over time, from its formation to the mature structure. The paraxial mesoderm is the mesoderm located bilaterally adjacent to the notochord and neural tube.

FGFR1, YAP1, TCF15, TEAD2

GO:0048340

BP

paraxial mesoderm morphogenesis

The process in which the anatomical structures of the paraxial mesoderm are generated and organized.

SMAD3, SMAD2

GO:0048341

BP

paraxial mesoderm formation

The process that gives rise to the paraxial mesoderm. This process pertains to the initial formation of the structure from unspecified parts.

WNT5A, FOXC1, EXOC4

GO:0048352

BP

paraxial mesoderm structural organization

The process that contributes to the act of creating the structural organization of the paraxial mesoderm. This process pertains to the physical shaping of a rudimentary structure.

BMPR1A

GO:0048368

BP

lateral mesoderm development

The process whose specific outcome is the progression of the lateral mesoderm over time, from its formation to the mature structure.

BMPR1A, YAP1, TEAD2

GO:0048378

BP

regulation of lateral mesodermal cell fate specification

Any process that modulates the frequency, rate or extent of lateral mesoderm cell fate specification.

FGFR1, BMPR1A

GO:0048382

BP

mesendoderm development

The process whose specific outcome is the progression of the mesendoderm over time, from its formation to the mature structure. In animal embryos, mesendoderm development gives rise to both mesoderm and endoderm tissues.

BMPR1A, ZFP36L1

GO:0048384

BP

retinoic acid receptor signaling pathway

The series of molecular signals generated as a consequence of a retinoic acid receptor binding to one of its physiological ligands.

TBX1, ACTN4, ALDH1A2, RXRB, NR1H2, CREM, KMT2E, CYP26B1

GO:0048385

BP

regulation of retinoic acid receptor signaling pathway

Any process that modulates the frequency, rate or extent of retinoic acid receptor signaling pathway activity.

AKR1C3

GO:0048386

BP

positive regulation of retinoic acid receptor signaling pathway

Any process that activates or increases the frequency, rate or extent of retinoic acid receptor signaling pathway activity.

CTBP2

GO:0048387

BP

negative regulation of retinoic acid receptor signaling pathway

Any process that stops, prevents, or reduces the frequency, rate or extent of retinoic acid receptor signaling pathway activity.

CNOT1, CYP26A1, DHRS3, CALR, EZH2, CYP26B1

GO:0048388

BP

endosomal lumen acidification

Any process that reduces the pH of the endosomal lumen, measured by the concentration of the hydrogen ion.

CLCN3

GO:0048389

BP

intermediate mesoderm development

The process whose specific outcome is the progression of the intermediate mesoderm over time, from its formation to the mature structure. The intermediate mesoderm is located between the lateral mesoderm and the paraxial mesoderm. It develops into the kidney and gonads.

OSR1

GO:0048392

BP

intermediate mesodermal cell differentiation

The process in which a relatively unspecialized cell acquires specialized features of an intermediate mesoderm cell.

BMP4

GO:0048468

BP

cell development

The process whose specific outcome is the progression of the cell over time, from its formation to the mature structure. Cell development does not include the steps involved in committing a cell to a specific fate.

MSTN, IRF6, GDF9, MAF, GDF11, BMP15, INHA, INHBA, INHBB, BMP3, BMP1, BMP8B, GJC1, GDF5, GATA4, INHBC, ARID5B, BMP8A, GATA6, GDF15, TRPS1

GO:0048469

BP

cell maturation

A developmental process, independent of morphogenetic (shape) change, that is required for a cell to attain its fully functional state.

TUSC2, GDF11, FGFR1, VEGFA, CTNNB1, PPARG, ASCL1, SOX8, PLP1, ID2, RUNX2, CBFB, HES1, EPAS1

GO:0048477

BP

oogenesis

The complete process of formation and maturation of an ovum or female gamete from a primordial female germ cell. Examples of this process are found in Mus musculus and Drosophila melanogaster.

DIAPH2, ERCC1, MLH1, H3F3A, TRIP13, ASPM, PAQR8, PAQR5, FMN2, DDX20, KIAA0430

GO:0048478

BP

replication fork protection

Any process that prevents the collapse of stalled replication forks.

BRCA2, BLM, FBXO18, TIPIN

GO:0048484

BP

enteric nervous system development

The process whose specific outcome is the progression of the enteric nervous system over time, from its formation to the mature structure. The enteric nervous system is composed of two ganglionated neural plexuses in the gut wall which form one of the three major divisions of the autonomic nervous system. The enteric nervous system innervates the gastrointestinal tract, the pancreas, and the gall bladder. It contains sensory neurons, interneurons, and motor neurons. Thus the circuitry can autonomously sense the tension and the chemical environment in the gut and regulate blood vessel tone, motility, secretions, and fluid transport. The system is itself governed by the central nervous system and receives both parasympathetic and sympathetic innervation.

EDNRA, SOX8, PHACTR4

GO:0048485

BP

sympathetic nervous system development

The process whose specific outcome is the progression of the sympathetic nervous system over time, from its formation to the mature structure. The sympathetic nervous system is one of the two divisions of the vertebrate autonomic nervous system (the other being the parasympathetic nervous system). The sympathetic preganglionic neurons have their cell bodies in the thoracic and lumbar regions of the spinal cord and connect to the paravertebral chain of sympathetic ganglia. Innervate heart and blood vessels, sweat glands, viscera and the adrenal medulla. Most sympathetic neurons, but not all, use noradrenaline as a post-ganglionic neurotransmitter.

NTRK1, ASCL1, SOX4, SEMA3A

GO:0048488

BP

synaptic vesicle endocytosis

Clathrin-mediated endocytosis of presynaptic membrane that recycles synaptic vesicle membrane and its components following synaptic vesicle exocytosis. This process starts with coating of the membrane with adaptor proteins and clathrin prior to invagination and ends when uncoating has finished.

SYNJ1, PIP5K1C, SYT1, CANX, SNCA, CDK5, ITSN1, DENND1A, SH3GL2, PACSIN1

GO:0048489

BP

synaptic vesicle transport

The directed movement of synaptic vesicles.

TOR1A, SYNJ1, SNAPIN, CTNNB1, RAB27A, DPYSL2

GO:0048490

BP

anterograde synaptic vesicle transport

The directed movement of synaptic vesicle along axonal microtubules from the cell body to the presynapse.

AP3D1, SNAPIN, AP3M2, AP3S2, BLOC1S1, BLOC1S3, BLOC1S6, AP3M1

GO:0048496

BP

maintenance of animal organ identity

The process in which the identity of an animal organ is maintained. Identity is considered to be the aggregate of characteristics by which a structure is recognized.

NPHP3, GPR98, PKP2

GO:0048499

BP

synaptic vesicle membrane organization

A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of the membrane surrounding a synaptic vesicle.

AP3D1

GO:0048505

BP

regulation of timing of cell differentiation

The process controlling the activation and/or rate at which relatively unspecialized cells acquire specialized features. Any process that modulates the rate, frequency or extent of the XXX at a consistent predetermined time point during its development.

SERPINE2, FGF9

GO:0048511

BP

rhythmic process

Any process pertinent to the generation and maintenance of rhythms in the physiology of an organism.

ROCK2, TOP2A, DDX5, SFPQ, PPARG, NKX2-1, MAPK8, MAPK9, PRKAA2, SIK1, RACK1, PRKDC, CDK5, CBX3, NR1D2, TWIST1, EZH2, HLF, CCAR2, NLGN1, ENOX1, PSPC1, CREBBP, KAT2B, SUV39H2, KDM5B, BTRC

GO:0048512

BP

circadian behavior

The specific behavior of an organism that recurs with a regularity of approximately 24 hours.

USP2, TP53, CSNK1E, BTBD9

GO:0048513

BP

animal organ development

Development of a tissue or tissues that work together to perform a specific function or functions. Development pertains to the process whose specific outcome is the progression of a structure over time, from its formation to the mature structure. Organs are commonly observed as visibly distinct structures, but may also exist as loosely associated clusters of cells that work together to perform a specific function or functions.

HTT

GO:0048514

BP

blood vessel morphogenesis

The process in which the anatomical structures of blood vessels are generated and organized. The blood vessel is the vasculature carrying blood.

TBX1, GJA1, CDH2, RASA1, NR2F2, FLT4, ID1, SYK, SOS1, CYP1B1

GO:0048515

BP

spermatid differentiation

The process whose specific outcome is the progression of a spermatid over time, from initial commitment of the cell to a specific fate, to the fully functional differentiated cell.

NPHP1, BAX, MAST2, RHBDD1

GO:0048524

BP

positive regulation of viral process

Any process that activates or increases the frequency, rate or extent of a multi-organism process in which a virus is a participant.

VPS4B, RAB7A, MVB12A

GO:0048525

BP

negative regulation of viral process

Any process that stops, prevents, or reduces the frequency, rate or extent of a multi-organism process in which a virus is a participant.

APCS, MBL2, APOBEC3G

GO:0048532

BP

anatomical structure arrangement

The process that gives rise to the configuration of the constituent parts of an anatomical structure. This process pertains to the physical shaping of a rudimentary structure. Anatomical structures can be macroscopic such as a carpel, or microscopic such as an acrosome.

RAC1